DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20200997

Vitamin B12 deficiency in patients of type 2 diabetes mellitus treated with metformin: a cross section observational study from a tertiary care centre in Sub-Himalayan region of North India

Laxmi Nand, Sunita Mahto, Dalip K. Garg, Bhupender Kumar

Abstract


Background: Metformin is first line of treatment in type 2 diabetes mellitus (T2DM). It has been reported to be associated with vitamin B12 deficiency with variable results in various studies. The aim of our study is to correlate metformin use and vitamin B12 levels in patients of T2DM with high prevalence in Sub-Himalyan region of north India.

Methods: The study was conducted from August 2017 to July 2018 enrolling 124 patients, aged 18 years and above with T2DM taking metformin treatment for >4 months. Vitamin B12 levels were estimated and the levels <200, 200-300 and >300 pg/ml were defined as having definite deficiency, borderline deficiency and normal levels respectively.

Results: A total of 124 patients included 66 (53.2%) male and 58 (46.8%) female patients with T2DM on metformin treatment. The mean vitamin B12 level was found significantly low, 176.23±60.96 pg/ml and 18 (14.5%) patients were found to have significant vitamin B12 deficiency and 8(6.5%) patients, borderline deficiency in longer duration of metformin use for >10 years (p<0.001). Vitamin B12 deficiency was found significantly more in 14 (11.3%) patients taking lower doses ≤1000 mg/day of metformin compared to higher doses, a negative correlation. Peripheral neuropathy was significantly present in 15.3% of patients in metformin induced vitamin B12deficiency.

Conclusions: Vitamin B12 deficiency was found to be significantly correlated to longer duration of metformin treatment and neuropathy in T2DM but negatively correlated to higher doses of metformin. Therefore, we recommend the assessment and supplementation of vitamin B12 in metformin use in T2DM, compromising financial burden but not the outcome of its deficiency.


Keywords


Peripheral neuropathy, Type 2 diabetes mellitus, Metformin, Vitamin B12 deficiency

Full Text:

PDF

References


American diabetes association. Standards of Medical Care in Diabetes-2018. Diab Care. 2018;41(Supplement1):S1-S2.

American Diabetes Association. Standards of medical care in diabetes: 2013. Diab Care. 2013; 36:11-66.

Scarpello JH, Howlett HC. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008;5(3):157-67.

de Benoist B. Conclusions of a WHO Technical Consultation on folate and vitamin B12 deficiencies. Food Nutr Bull. 2008 Jun;29(2_suppl1):S238-44.

Kumthekar AA, Gidwani HV, Kumthekar AB. Metformin Associated B12 Deficiency. J Assoc Physicians India. 2012;60:58-9.

Reinstatler L, Qi YP, Williamson RS, Garn JV, Oakley GP. Association of biochemical B12 deficiency with metformin therapy and vitamin B12 supplements: the National Health and Nutrition Examination Survey, 1999-2006. Diab Care. 2012 Feb 1;35(2):327-33.

Iftikhar R, Kamran SM, Qadir A, AIqbal Z, Bin Usman H. Prevalence of vitamin B12 deficiency in patients of type 2 diabetes mellitus on metformin: a case control study from Pakistan. Pan Afr Med J. 2013;16:67.

Andre`s E, Noel E, Goichot B. Metformin-associated vitamin B12 deficiency. Arch Intern Med. 2002;162:2251-2.

De-Jager J, Kooy A, Lehert P, Wulffele MG, van der Kolk J, Bets D, et al. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ. 2010;340:c2181.

Akinlade KS, Agbebaku SO, Rahamon SK, Balogun WO. Vitamin B12 levels in patients with type 2 diabetes mellitus on metformin. Ann Ibd Pg Med. 2015;13:79-83.

Hermann LS, Nilsson BO, Wettre S. Vitamin B12 status of patients treated with metformin: a cross-sectional cohort study. Br J Diab Vasc Dis. 2004;4:401-6.

Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaqust D, Topolski R. The Prevalence of Vitamin B12 Deficiency in Patients with Type 2 Diabetes: A Cross-Sectional Study. J Am Board Fam Med. 2009;22:528-34.

Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM. Risk Factors of Vitamin B12 Deficiency in Patients Receiving Metformin. Arch Intern Med. 2006;166:1975-9.

Nervo M, Lubini A, Raimundo FV, Faulhaber GA, Leite C, Fischer LM, et al. Vitamin B12 in metformin treated diabetic patients, a cross sectional study in Brazil. Revista DA Assoc Med Bras. 2011;57(1):46-9.

Wulffele MG, Kooy A, Lehert P, Bets D, Ogterop J C, Borger van der B, et al. Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate, and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med. 2003;254:455-63.

Bauman WA, Shaw S, Jayatilleke E, Spungen AM, Herbert V. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin. Diab Care. 2000; 23:1227-31.

Yajnik, CS, Deshpande SS, Lubree HG, Naik SS, Bhat DS, Uradev BS, et al. Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians. J Assoc Physicians India. 2006;54:775-82.

Allen LH. How common is vitamin B12 deficiency? Am J Clin Nutr. 2009;89:693S-6S.

Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurol. 1995;45:1435-40.

Green, R. Vitamin B12 deficiency from the perspective of a practicing hematologist. A recent and authoritative up-to-date summary of the clinical aspects of B12 deficiency with emphasis on the haematological perspective. Blood. 2017;129:2603-11.

Ingole JR, Patel RD, Ingole SJ, Pandave HT. Opportunistic screening of Vitamin B12 deficiency in IT professionals presenting for routine health check-up. J Clin Diagn Res. 2015;9:01-2.

Nereddy VA, Boddikuri IP, Ubedullah SK, Papareddy A, Miriyam MK. Correlation of Vit B12 levels with metformin usage among type 2 diabetic patients in a tertiary care hospital. Int J Adv Med. 2018;5:1128-32.

Pongchaidecha M, Srikusalanukul V, Chattananon A, Tanjariyaporn S. Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: a cross-sectional study in patients with type 2 diabetes mellitus. J Med Assoc Thai. 2004; 87:780-7.

Qureshi S, Ainsworth A, Winocour P. Metformin therapy and assessment for vitamin B12 deficiency: is it necessary? Pract Diab. 2011;28:302-4.

Agarwal P, Mital P, Meena VK, Mital P, Nawal CL, Goyal LK. A comparative study of levels of vitamin B12 in patients of type 2 diabetes mellitus on metformin and not on metformin at tertiary care center. Int J Adv Med. 2016;3:759-63.

American Diabetes Association. Pharmacologic approaches to glycemic treatment. Diab Care. 2017;40(Supplement 1):S64-S74.

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998; 352:854-65.

Nagrebetsky A, Griffin S, Kinmonth AL, Sutton S, Craven A, Farmer A. Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age. Diabetes Res Clin Pract. 2012;96(2):119-28.

Kang D, Yun JS, Ko SH, Lim TS, Ahn YB, Park YM, et al. Higher prevalence of metformin-induced vitamin B12 deficiency in sulfonylurea combination compared with insulin combination in patients with type 2 diabetes: a cross-sectional study. PLoS One 2014;9:e109878.

Malin SK, Kashyap SR. Effects of metformin on weight loss: potential mechanisms. Curr Opin Endocrinol Diabetes Obes. 2014;21:323-9.

Rees JA, Dunstan DF, Chen S, Lansdown JA, Moat SJ, Ellis R, et al. An observational study of the effect of metformin on B12 status and peripheral neuropathy. Br J Diabetes Vasc Dis. 2012;12:189-93.

Singh AK, Kumar A, Karmakar D, Jha RK. Association of B12 deficiency and clinical neuropathy with metformin use in type 2 diabetes patients. J Postgrad Med. 2013;59(4):253-7.